PubMed Health⌕ Search

Biomedical subjects

A Nikolić

Publications and source records attributed to A Nikolić.

35 records · Page 2Linked to original sources
PubMed1982

[Euthanasia].

Explore the source record for details and available documents.

Ethics, Medical↗
PubMedDate not supplied

[Levels of fetal fibronectin in the cervix and vagina during pregnancy].

INTRODUCTION: Fibronectin is a glycoprotein produced by different types of cells. It can be divided into two main groups--soluble fibronectin, found in human plasma and other body fluids (amniotic fluid) and tissue fibronectin, found in basal membrane and connective tissue between endothelial cells (2). There are three subtypes--plasmatic, cellular and onco-fetal fibronectin, the most important during pregnancy, with different concentrations during the course of pregnancy. The aim of the study is to establish normal distribution of fetal fibronectin in cervicovaginal fluid during pregnancy in our population and afterwards establish the relation between concentrations in different stages of pregnancy and the pregnancy outcome. MATERIAL AND METHODS: This prospective, observational study was done at the Department of Obstetrics and Gynaecology, Clinical Centre Novi Sad, during the period June-October 1988. The presented results are preliminary ones. The patients were randomly chosen from the population that came for routine consultations as well as the ones hospitalized at the Department, at the High Risk Pregnancy Unit, for reasons other than threatening miscarriage and preterm delivery. One-hundred and thirty two pregnant women were examined, divided into three groups, according to gestational age. In group I were women between 7-20 weeks, in group II between 21 and 37 weeks and in group III 38 and more weeks. In every case general and obstetric data were collected, and cervico-vaginal fibronectin was taken from the posterior vaginal fornix, using a special kit (Specimen Collection Package, Adeza Biomedical). Fetal fibronectin concentration was tested using enzyme immunoassay (Adeza Biomedical) and positive was considered the concentration of and above 0.05 microgram/ml. RESULTS: The mean cervico-vaginal fibronectin concentration, uncorrected for the outcome of the pregnancy was as follows--in group I 0.045 (0-0.11) microgram/ml, group II 0.037 (0-1.22) microgram/ml, and in group III 0.226 (0.001-1.05) microgram/ml. The concentration trend was from weakly negative during the period 7-20 weeks, over highly negative (21-37 weeks) to very positive, after 38 weeks. The positive/negative relation in group I was 29.2%/70.8%, group II 11.7%/88.3% and group III 48.4%%/51.6%. After the correction of the results for miscarriages/preterm deliveries/failed induction in postterm pregnancies, the mean concentrations were somewhat different--group I 0.029 microgram/ml, II 0.019 microgram/ml and III 0.282 microgram/ml. The relations of positive and negative results were changed as well and in group I the relation was 27.3%/72.7%, group II 6.8%/93.2% and group III 71.4%/28.6%. DISCUSSION: After the correction for duration and outcome of the pregnancy, our results differed from the results in the literature. Thus in the 1st trimester fetal fibronectin was positive in cervico-vaginal fluid of 27.3% pregnant women, which is double the number usually found in the literature, between 21 and 37 weeks, when a positive result (> 0.05 microgram/ml) would be expected in only 3% of cases, it was positive in 6.8%, whereas 2.3 of the women delivered at term had a positive concentration. The discrepancy in group II (21-37 weeks) cannot be explained neither with a higher incidence of late miscarriages, nor preterm deliveries, for the incidence of such complications was only 3%, which is far less than usually found in the non-selected population (10%) (9). It is also possible that the discrepancy in our results and the results found in literature is based on a fact that our population was not preselected, which was the case in other studies' populations that did not include women with heavy, non-treated vaginal discharge, nor the ones that had sexual intercourse within 24 hours from the moment of fibronectin sampling. (ABSTRACT TRUNCATED)

Adult↗
PubMedDate not supplied

[Development of highly specialized clinical drug trial units within health care institutions].

The purpose of the most of clinical trials conducted under the auspices of pharmaceutical industries is to evaluate the safety and efficacy of drugs, and they are conducted at university health care institutions or appropriate clinical centres. Close collaboration among the investigators, potential investigators and other academic citizens is essential for an effective and efficient conduct of these studies. Clinical studies usually test a drug which is to be instituted for the first time; therefore more attention is being dedicated to its administration, with monitoring of a greater number of valid parameters in accordance with the Good Clinical Practices (GCP) and Good Laboratory Practices (GLP) standards. These are very strict standards, which have been internationally adopted and are valid worldwide. They define the documentation required, the setting method, the necessary equipment and the facilities within which the clinical trials are to be conducted, as well as human resources indispensable for carrying out the clinical trials. The objective of this paper was to determine whether our medical instructions fulfil the necessary conditions for establishing the clinical trials units. Creation of a symbiosis of this kind (between the pharmaceutical industry and the appropriate health care institutions), reflected in the clinical trials unit, should enable the drug research and development to remain within our country.

Clinical Trials as Topic↗
PubMedDate not supplied

[Health care cooperatives. The role and contributions of this movement in the protection and improvement of the national health status from 1921 to 1949].

After the First World War in the devastated and destroyed country, besides hard economic problems, also many social and sanitary problems required appropriate solutions. Loss of a great number of physicians and other sanitary personnel during the war was badly reflected on health care of the population, especially in rural areas. In these conditions and on suggestions made by a young physician, dr. Gavrilo Kojitsh (Gavrilo Kojić), many health cooperatives were established. Funds were secured by membership fees payed by the members to the so-called patients' funds. These financial resources were intended for covering of expenses in case of illness or death of a cooperative member or a member of his family. Monthly payment depended on the number of family members and degree of health insurance. A cooperative was composed of 300-500 families. The first health cooperatives were established in 1921 and up to 1939 there were 87 cooperatives with 97 physicians and 71 pharmacists. The price of a doctor's consultation was 3-4 times smaller than that in a private doctor's office, and prices of medications and drugs were reduced. In addition to curative treatment, the outpatient service of these cooperatives included maternal and infant care centres with visiting nursing service, sections for fight against infectious disease (vaccination), especially tuberculosis, education, rebuilding of villages, better water-supply, etc. In 1949 these health cooperatives were integrated into the new system of public health services.

Delivery of Health Care↗
PubMedDate not supplied

[Intestinal parasitic infections in Serbia].

To determine the public health significance of intestinal parasitism in Serbia today, systematic parasitologic examination of 16 regions (Kragujevac, Luchani, Zhagubica, Bor, Sjenica, Novi Pazar, Valjevo, Aleksandrovac, Pirot, Bosilegrad, Ivanjica, Golubac, Uzhice, Kladovo, Negotin, Beograd) in central Serbia were carried out over the period 1984-1993. The study involved a total of 5981 schoolchildren (2887 F, 3094 M), 7-11 years old representing 10% of the total age-matched population (N = 58,228) of the examined regions, residing in 91 settlements. Field parasitological examinations included the examination of perianal swabs for E. vermicularis and Taenia sp., and examination of a single feces sample by direct saline smear and Lugol stained smear for intestinal protozoa, and the Kato and Lörincz methods for intestinal helminths. Nine species of intestinal parasites were detected, of which five protozoan: Entamoeba histolytica (0.02%), Entamoeba hartmanni (0.02%), Entamoeba coli (1.3%), Iodamoeba bütschlii (0.02%), Giardia lamblia (6.8%), and four helminthic: Hymenolepis nana (0.06%), Enterobius vermicularis (14.7%), Ascaris lumbricoides (3.3%), Trichuris trichiura (1.8%). The overall prevalence of intestinal parasite infections amounted to 24.6% (1207/4913), with a highly significant difference (p < 0.001) between particular sites (range 14.4%-43.8%) (Figure 1). Helminthic infections (810) were significantly more frequent (p < 0.001) as compared to both protozoan (296) and combined helminthic-protozoan infections (101). Of these, two species (G. lamblia, E. vermicularis) were found in all examined regions, three (E. coli, A. lumbricoides, T. trichiura) were detected in two or more, while four species (E. histolytica, E. hartmanni, I. bütschlii, H. nana) were each found in a single region (Figure 2). The predominant species (E. coli, G. lamblia, E. vermicularis, A. lumbricoides, T. trichiura) were distributed at considerably different prevalence rates, with a significant difference between the minimal and maximal values (p < 0.01). Of 91 settlements examined, intestinal parasites were found in all but one. However, the prevalence rates in 90 settlements varied significantly (p = 0.0004), from a low of 5.9% to a high of 66.7%. Thus, according to the World Health Organization criteria [19], infections with the four clinically relevant species (G. lamblia, E. vermicularis, A. lumbricoides, T. trichiura) ranged from sporadic to endemic and hyperendemic (Figure 3). The results obtained provide the basic epidemiological data about intestinal parasite infections in Serbia, and indicate their significance in terms of both the number of species and their respective prevalence rates. Given the significant differences obtained in the frequency and distribution of particular parasite infections in different regions, a programme for the control of these infections in Serbia should obviously include a wide variety of measures.

Adolescent↗